OncoMark Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 5

Employees

  • Latest Deal Type
  • M&A

OncoMark General Information

Description

Developer of a healthcare device intended to cut the number of patients receiving chemotherapy unnecessarily. The company's device detects early-stage breast cancer by measuring the expression of prognostic genes and estimates the probability of distant recurrence of cancer, enabling clinicians to determine treatment options for their patients and ultimately improving the patent's quality of life.

Contact Information

Website
www.oncomark.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • NovaUCD, Belfield Innovation Park
  • Belfield
  • Dublin
  • Ireland
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Acquirer
Cepheid
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • NovaUCD, Belfield Innovation Park
  • Belfield
  • Dublin
  • Ireland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OncoMark Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 01-Mar-2021 Completed Generating Revenue
5. Later Stage VC 01-Jan-2019 Completed Generating Revenue
4. Later Stage VC 01-Jan-2017 Completed Generating Revenue
3. Grant 09-Sep-2015 Completed Startup
2. Grant $3.89M Completed Startup
1. Accelerator/Incubator 01-Jan-2007 Completed Startup
To view OncoMark’s complete valuation and funding history, request access »

OncoMark Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a healthcare device intended to cut the number of patients receiving chemotherapy unnecessarily. The compan
Diagnostic Equipment
Dublin, Ireland
5 As of 2022

Irvine, CA
 

Boston, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

OncoMark Competitors (4)

One of OncoMark’s 4 competitors is Agendia, a Venture Capital-Backed company based in Irvine, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Agendia Venture Capital-Backed Irvine, CA
Nimbus Therapeutics Venture Capital-Backed Boston, MA
OrigiMed Venture Capital-Backed Shanghai, China
Metacrine Formerly VC-backed San Diego, CA
To view OncoMark’s complete competitors history, request access »

OncoMark Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OncoMark Former Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Danaher Industrial Controls Group Corporation Minority
Enterprise Ireland Growth/Expansion Minority
European Commission Government
Halo Business Angel Network Angel Group Minority
Horizon 2020 Government
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

OncoMark FAQs

  • When was OncoMark founded?

    OncoMark was founded in 2007.

  • Where is OncoMark headquartered?

    OncoMark is headquartered in Dublin, Ireland.

  • What is the size of OncoMark?

    OncoMark has 5 total employees.

  • What industry is OncoMark in?

    OncoMark’s primary industry is Diagnostic Equipment.

  • Is OncoMark a private or public company?

    OncoMark is a Private company.

  • What is OncoMark’s current revenue?

    The current revenue for OncoMark is .

  • How much funding has OncoMark raised over time?

    OncoMark has raised $6.99M.

  • Who are OncoMark’s investors?

    Danaher Industrial Controls Group, Enterprise Ireland, European Commission, Halo Business Angel Network, and Horizon 2020 are 5 of 8 investors who have invested in OncoMark.

  • Who are OncoMark’s competitors?

    Agendia, Nimbus Therapeutics, OrigiMed, and Metacrine are competitors of OncoMark.

  • When was OncoMark acquired?

    OncoMark was acquired on 01-Mar-2021.

  • Who acquired OncoMark?

    OncoMark was acquired by Cepheid.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process